KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Clover Health Investments (CLOV) Operating Expenses (2019 - 2025)

Clover Health Investments' Operating Expenses history spans 7 years, with the latest figure at $537.0 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 49.84% year-over-year to $537.0 million; the TTM value through Dec 2025 reached $2.0 billion, up 41.85%, while the annual FY2025 figure was $2.0 billion, 41.85% up from the prior year.
  • Operating Expenses reached $537.0 million in Q4 2025 per CLOV's latest filing, up from $521.0 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $961.9 million in Q1 2022 to a low of -$1.5 billion in Q4 2022.
  • Average Operating Expenses over 5 years is $419.2 million, with a median of $432.6 million recorded in 2023.
  • Peak YoY movement for Operating Expenses: soared 299.12% in 2021, then crashed 335.77% in 2022.
  • A 5-year view of Operating Expenses shows it stood at $618.8 million in 2021, then plummeted by 335.77% to -$1.5 billion in 2022, then soared by 125.74% to $375.5 million in 2023, then decreased by 4.56% to $358.4 million in 2024, then soared by 49.84% to $537.0 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Operating Expenses are $537.0 million (Q4 2025), $521.0 million (Q3 2025), and $488.2 million (Q2 2025).